MEDIGYN: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
MEDIGYN
Largest movements
- Cash +€52,846
up €52,846 (+130.1%), from €40,625 to €93,470
mainly Other debts (+€41,104) and Depreciation (+€31,484)
- Tangible fixed assets -€24,813
down €24,813 (-6.8%), from €364,007 to €339,193
- Receivables within one year -€8,515
down €8,515 (-78.4%), from €10,863 to €2,348
of which Other amounts receivable: -€7,515
- Other debts +€41,104
up €41,104 (+66.8%), from €61,548 to €102,652
- Current portion of long-term debt -€11,449
down €11,449 (-53.1%), from €21,572 to €10,124
- Debts after one year -€10,124
no longer reported in 2025 (was €10,124)
- Profit (loss) carried forward +€5,567
up €5,567, from -€5,384 to €183
- Financial charges -€12,525
down €12,525 (-33.1%), from €37,843 to €25,318
- Gross operating margin +€8,640
up €8,640 (+15.9%), from €54,344 to €62,984
- Depreciation -€4,894
down €4,894 (-13.5%), from €36,378 to €31,484
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €480,446 | €501,699 | +€21,252 | +4.4% |
| Fixed assets | 21/28 | €364,007 | €339,193 | -€24,813 | -6.8% |
| Tangible fixed assets | 22/27 | €364,007 | €339,193 | -€24,813 | -6.8% |
| Land and buildings | 22 | €322,296 | €315,453 | -€6,844 | -2.1% |
| Plant, machinery and equipment | 23 | €6,455 | - | -€6,455 | |
| Furniture and vehicles | 24 | €35,255 | €23,741 | -€11,514 | -32.7% |
| Current assets | 29/58 | €116,440 | €162,505 | +€46,065 | +39.6% |
| Amounts receivable within one year | 40/41 | €10,863 | €2,348 | -€8,515 | -78.4% |
| Trade receivables | 40 | €1,000 | - | -€1,000 | |
| Other amounts receivable | 41 | €9,863 | €2,348 | -€7,515 | -76.2% |
| Current investments | 50/53 | €50,000 | €50,000 | = | 0.0% |
| Cash at bank and in hand | 54/58 | €40,625 | €93,470 | +€52,846 | +130.1% |
| Deferred charges and accrued income | 490/1 | €14,952 | €16,687 | +€1,735 | +11.6% |
| Total equity and liabilities | 10/49 | €480,446 | €501,699 | +€21,252 | +4.4% |
| Equity | 10/15 | €379,586 | €385,153 | +€5,567 | +1.5% |
| Contributions | 10/11 | €12,400 | €12,400 | = | 0.0% |
| Reserves | 13 | €372,570 | €372,570 | = | 0.0% |
| Non-distributable reserves | 130/1 | €372,570 | €372,570 | = | 0.0% |
| Reserves not available under the articles | 1311 | €372,570 | €372,570 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€5,384 | €183 | +€5,567 | |
| Amounts payable | 17/49 | €100,860 | €116,546 | +€15,685 | +15.6% |
| Amounts payable after more than one year | 17 | €10,124 | - | -€10,124 | |
| Financial debts | 170/4 | €10,124 | - | -€10,124 | |
| Amounts payable within one year | 42/48 | €89,178 | €114,948 | +€25,771 | +28.9% |
| Current portion of amounts payable after more than one year | 42 | €21,572 | €10,124 | -€11,449 | -53.1% |
| Trade debts | 44 | €3,557 | €2,172 | -€1,385 | -38.9% |
| Suppliers | 440/4 | €3,557 | €2,172 | -€1,385 | -38.9% |
| Taxes, remuneration and social security | 45 | €2,500 | - | -€2,500 | |
| Remuneration and social security | 454/9 | €2,500 | - | -€2,500 | |
| Other amounts payable | 47/48 | €61,548 | €102,652 | +€41,104 | +66.8% |
| Accrued charges and deferred income | 492/3 | €1,559 | €1,597 | +€38 | +2.5% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €36,378 | €31,484 | -€4,894 | -13.5% |
| Other operating charges | 640/8 | €393 | €497 | +€104 | +26.4% |
| Gross operating margin | 9900 | €54,344 | €62,984 | +€8,640 | +15.9% |
| Operating profit (loss) | 9901 | €17,573 | €31,003 | +€13,431 | +76.4% |
| Financial income | 75/76B | €86 | €34 | -€52 | -60.3% |
| Recurring financial income | 75 | €86 | €34 | -€52 | -60.3% |
| Financial charges | 65/66B | €37,843 | €25,318 | -€12,525 | -33.1% |
| Recurring financial charges | 65 | €37,843 | €25,318 | -€12,525 | -33.1% |
| Profit (loss) for the period before taxes | 9903 | -€20,185 | €5,719 | +€25,904 | |
| Income taxes | 67/77 | €163 | €152 | -€11 | -6.6% |
| Profit (loss) for the period | 9904 | -€20,348 | €5,567 | +€25,915 | |
| Profit (loss) for the period to be appropriated | 9905 | -€20,348 | €5,567 | +€25,915 |
Source: filed annual accounts (NBB), fiscal years ended 31 August 2024 and 31 August 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 5 October 2026 via checked.be.